ENTRY       D11237                      Drug
NAME        Lifastuzumab (USAN)
FORMULA     C6504H10028N1744O2018S46
EXACT_MASS  146324.2834
MOL_WEIGHT  146414.6791
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFSFS DFAMSWVRQA PGKGLEWVAT IGRVAFHTYY
            PDSMKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARHR GFDVGHFDFW GQGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
            MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRSSETLV HSSGNTYLEW YQQKPGKAPK LLIYRVSNRF
            SGVPSRFSGS GSGTDFTLTI SSLQPEDFAT YYCFQGSFNP LTFGQGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H147-H203, H223-L219, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'219, H'264-H'324, H'370-H'428, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-NaPi-IIb antibody
  TYPE      Monoclonal antibody
TARGET      SLC34A2 [HSA:10568] [KO:K14683]
  PATHWAY   hsa04928(10568)  Parathyroid hormone synthesis, secretion and action
            hsa04978(10568)  Mineral absorption
BRITE       Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC34
                SLC34A2
                 D11237  Lifastuzumab (USAN)
DBLINKS     CAS: 1615697-16-9
            PubChem: 384585215
///
